Abstract
Distorted erythrocytes in the urine or dysmorphic erythrocyturia and erythrocyte casts with no clot formation are characteristic features of renal parenchymal hematuria, often seen in glomerulonephritis and infrequently in interstitial nephritis. In addition to these features, the presence of proteinuria that exceeds the amounts estimated from local bleeding, such as in pelvic or ureteral stone, bladder tumor, is also an evidence of glomerular hematuria. Glomerular hematuria is almost universally observed in both primary and secondary glomerulonephritides.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Berger J, Hinglais N: Les dépôts intercapillaires d’IgA-IgG. J Urol Néphrol 74:694–695, 1968.
Woodroffe AJ, Gormly AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR: Immunologic studies in IgA nephropathy. Kidney Int 18:366–374, 1980.
Tung KSK, Woodroffe AJ, Ahlin TD, Williams RC, Wilson CB: Applications of the solid phase Clq and Raji cell radioimmunoassays for the detection of circulating immune complexes in glomerulonephritis. J Clin Invest 62:61–72, 1978.
Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ: IgA-containing circulating immune complexes in patients with IgA nephropathy. Am J Med 74:56–63, 1983.
Valentijn RM, Kauffman RH, Dela Reveliere GB, Daha MR, Van Es LA: Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med 74:375–381, 1983.
Berthoux FC, Gagne A, Sabatier JC, Ducret F, Le Petit JC, Marcelin M, Mercier B, Bizard CP: HLA-BW35 and mesan-gial IgA glomerulonephritis. N Engl J Med 298:1034–1035, 1978.
Nomoto Y, Endoh M, Miura M, Suga T, Tornino Y, Sakai H, Nose Y, Tsuji K: IgA nephropathy associated with HLA-DR4 antigen. Am J Nephrol 4:184–187, 1984.
D’Amico G, Imbasciati E, Barbiano di Belgioioso G, Bertoli S, Fogazzi G, Ferrano F, Fellin G, Ragni A, Colasanti G, Minetti L, Ponticelli C: Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine 64:49–60, 1985.
Götze O, Müller-Eberhard HJ: The C3 activator system: An alternate pathway of complement activation. J Exp Med 134:905–1085, 1971.
Clarkson AR, Seymour AE, Thompson AJ, Haynes WDG, Chan YL, Jackson B: IgA nephropathy: A syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 8:459–471, 1977.
Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7:232–241, 1975.
Rifai A, Small PA, Teague PO, Ayoub EM: Experimental IgA nephropathy. J Exp Med 150:1161–1173, 1979.
Nomoto Y, Sakai H, Arimori S: Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am J Clin Path 71:158–161, 1979.
Sakai H Nomoto Y, Arimori S, Komori K, Inouye H, Tsuji K: Increase of IgA bearing peripheral blood lymphocytes in families of patients with IgA nephrophthy. Am J Clin Path 72:452–456, 1979.
Egido J, Blasco R, Sancho J, Illescas M, Hernando L: Abnormalities of immune regulation in patients with IgA mesangial glomerulonephritis. Proc Eur Dial Transpl Assoc 19:642–647, 1983.
Sakai H, Endon M, Tornino Y, Nomoto Y: Increase of IgA specific helper Ta cells in patients with IgA nephrophathy. Clin Exp Immunol 50:77–82, 1982.
Lawrence S, Pussell BA, Charlesworth JA: Mesangial IgA nephropathy: Detection of defective reticulophagocytic function in vivo. Clin Nephrol 19:280–283, 1983.
Roccatello D, Coppo R, Piccoli G: Monocyte-macrophage system function in primary IgA nephropathy. Contr Nephrol 40:130–136, 1984.
Sato M, Kinugasa E, Ideura T, Koshikawa S: Phagocytic activity of polymorphonuclear leukocytes in patients with IgA nephropathy. Clin Nephrol 19:166–171, 1983.
Droz D, Noël LH: Ré-evaluation du prognostic des glomér-ulonephrites á dépôts intracapillaires d’IgA. Semin Nephrol Pédiat 1983:26–31, 1983.
Lagrue G, Sandreux T, Laurent J, Hirbec G: Is there a treatment of mesangial IgA glomerulonephritis? Clin Nephrol 16:161, 1981.
Mustonen J, Pasternack A, Rantala I: The nephrotic syndrome in IgA glomerulonephritis: Response to corticosteriod therapy. Clin Nephrol 20:172–176, 1983.
Kobayaski Y, Fujii K, Hiki Y, Tateno S: Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases. QJ Med New Series 61,234:935–943,1986.
Woo KT, Edmondson RPS, Yap HK, Wu AYT, Chiang GSC, Lee EJC, Pwee HS, Lim CH: Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 27:56–64, 1987.
Tornino Y, Sakai H, Miura, Suga T, Endoh M, Nomoto T: Effect of danazol on solubilization of immune deposits in patients with IgA Nephropathy. Am J Kidney Dis 14:135–140, 1984.
Egido J, Rivera F, Sancho J, Barat Am, Hernando L: Phenytoin in IgA nephropathy: A long-term controlled trial. Nephron 38:30–39, 1984.
Clarkson AR, Seymour AE, Woodroffe AJ, McKenzie PE, Chan L, Wootton AM: Controlled trial of phenytoin therapy in IgA nephropathy. Clin Nephrol 13:215–218, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ohno, J. (1991). Hematuria and IgA Nephropathy. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive